JESSICA CRAWFORD: Open Payments
NPI 1558305706 · TUCKER, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,673 in 89 payments from 15 companies in 2025. Trend: 2023 $949 · 2024 $1,454 · 2025 $1,673
Food & beverage: $1,573Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $310 |
| Janssen Biotech, Inc. | 13 | $214 |
| Regeneron Healthcare Solutions, Inc. | 12 | $186 |
| Novartis Pharmaceuticals Corporation | 9 | $158 |
| LEO Pharma Inc. | 7 | $152 |
| GENZYME CORPORATION | 6 | $138 |
| Almirall LLC | 4 | $114 |
| Organon LLC | 6 | $86 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $74 |
| Lilly USA, LLC | 3 | $68 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, Seysara, ADBRY, RINVOQ, LIBTAYO, COSENTYX.
Industry payments across GA — which companies pay providers there.
